Literature DB >> 23207509

Clinical, pathological, and genetic analysis of ten patients with MYH9-related disease.

Xiong-hua Sun1, Zhao-yue Wang, Hai-yan Yang, Li-juan Cao, Jian Su, Zi-qiang Yu, Xia Bai, Chang-geng Ruan.   

Abstract

MYH9-related disease (MYH9-RD) is an autosomal dominant disorder caused by mutations in the MYH9 gene. It is characterized by a triad of giant platelets, thrombocytopenia, and characteristic Döhle body-like granulocyte inclusions. In this study we report 10 unrelated patients with MYH9-RD in whom the following seven MYH9 gene mutations were found: W33R, p.Q1443_K1445dup, R702H, D1424N, E1841K, R1933X, and E1945X (the first two were novel mutations). The region of the MYH9 mutation determines in some regards the phenotype, but clinical expression can vary between individuals with the same mutation. The neutrophil inclusion bodies of two patients were too small to be detected, but could be found with immunofluorescence staining. Immunoblotting analysis revealed that the calculated NMMHC-IIA/β-actin ratio for MYH9-RD neutrophils was 39% of normal controls. Kidney biopsy showed segmental glomerulosclerosis and NMMHC-IIA expression was decreased in podocytes. This disease is not as rare as originally thought. In any individual with persistent macrothrombocytopenia and no response to corticosteroids and immunosuppressive agents, even if neutrophil inclusions were inconspicuous in routine staining, MYH9-RD should be suspected.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23207509     DOI: 10.1159/000342123

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  7 in total

1.  Macrothrombocytopenia With Döhle Body-Like Granulocyte Inclusions: A Case Report of May-Hegglin Anomaly in a 33-Year-Old White Woman With an Update on the Molecular Findings of MYH9-Related Disease.

Authors:  Steven M Ruhoy; Amanda Yates
Journal:  Lab Med       Date:  2016-06-28

Review 2.  The role of vertebrate nonmuscle Myosin II in development and human disease.

Authors:  Xuefei Ma; Robert S Adelstein
Journal:  Bioarchitecture       Date:  2014-08-06

3.  Myosin heavy chain-9-related disorders (MYH9-RD): a case report.

Authors:  Diana Vassallo; Ibi Erekosima; Durga Kanigicherla; Edmond O'Riordan; Puchimada Uthappa; Constantina Chrysochou
Journal:  Clin Kidney J       Date:  2013-09-01

4.  Cochlear implantation is safe and effective in patients with MYH9-related disease.

Authors:  Alessandro Pecci; Eva J J Verver; Nicole Schlegel; Pietro Canzi; Carlos M Boccio; Helen Platokouki; Eike Krause; Marco Benazzo; Vedat Topsakal; Andreas Greinacher
Journal:  Orphanet J Rare Dis       Date:  2014-06-30       Impact factor: 4.123

5.  Mutation spectrum and genotype-phenotype correlations in a large French cohort of MYH9-Related Disorders.

Authors:  Béatrice Saposnik; Sylvie Binard; Odile Fenneteau; Alan Nurden; Paquita Nurden; Marie-Françoise Hurtaud-Roux; Nicole Schlegel
Journal:  Mol Genet Genomic Med       Date:  2014-02-07       Impact factor: 2.183

6.  [The progresses in research and treatment of inherited platelet disorders].

Authors:  Z Y Wang; C G Ruan
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2018-10-14

7.  MYH9-related disorders display heterogeneous kidney involvement and outcome.

Authors:  Nahid Tabibzadeh; Dominique Fleury; Delphine Labatut; Frank Bridoux; Arnaud Lionet; Noémie Jourde-Chiche; François Vrtovsnik; Nicole Schlegel; Philippe Vanhille
Journal:  Clin Kidney J       Date:  2018-12-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.